My Cousin, My Enemy: quasispecies suppression of drug resistance

• Published in: Current opinion in virology Vol. 20; pp. 106 - 111
• Main Authors: Kirkegaard, Karla, van Buuren, Nicholas J., Mateo, Roberto
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.10.2016
• Subjects: Antiviral Agents - pharmacology; Dengue Virus - drug effects; Dengue Virus - physiology; Drug Resistance, Viral; Genetics, Population; Humans; Poliovirus - drug effects; Poliovirus - physiology; Selection, Genetic; Vesiculovirus - drug effects; Vesiculovirus - physiology; Virus Replication
• ISSN: 1879-6257; 1879-6265
• DOI: 10.1016/j.coviro.2016.09.011

•Drug targets can be chosen so that drug susceptibility is genetically dominant.•Dominant drug targets prevent the selection of drug-resistant viruses.•Oligomeric viral proteins can be dominant drug targets through co-assembly.•Dominant drug targeting is applicable to other intracellular polyploidy scenarios. If a freshly minted genome contains a mutation that confers drug resistance, will it be selected in the presence of the drug? Not necessarily. During viral infections, newly synthesized viral genomes occupy the same cells as parent and other progeny genomes. If the antiviral target is chosen so that the drug-resistant progeny's growth is dominantly inhibited by the drug-susceptible members of its intracellular family, its outgrowth can be suppressed. Precedent for ‘dominant drug targeting’ as a deliberate approach to suppress the outgrowth of inhibitor-resistant viruses has been established for envelope variants of vesicular stomatitis virus and for capsid variants of poliovirus and dengue virus. Small molecules that stabilize oligomeric assemblages are a promising means to an unfit family to destroy the effectiveness of a newborn drug-resistant relative due to the co-assembly of drug-susceptible and drug-resistant monomers.